61 related articles for article (PubMed ID: 38613793)
1. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
[TBL] [Abstract][Full Text] [Related]
2. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract][Full Text] [Related]
3. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction.
Zeng J; Li X; Zhang Y; Zhang B; Wang H; Bao S; Zu L; Zhang H; Cheng Y; Tang Q; Xu X; Xu S; Song Z
Aging (Albany NY); 2024 May; 16(9):7647-7667. PubMed ID: 38728250
[TBL] [Abstract][Full Text] [Related]
4. Unveiling HOXB7 as a novel diagnostic and prognostic biomarker through pan-cancer computer screening.
Li C; Mao X; Song L; Sheng J; Yang L; Huang X; Wang L
Comput Biol Med; 2024 Jun; 176():108562. PubMed ID: 38728993
[TBL] [Abstract][Full Text] [Related]
5. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
[TBL] [Abstract][Full Text] [Related]
6. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Sun X; Xin S; Jin L; Zhang Y; Ye L
Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma.
Tang Q; Chen YM; Shen MM; Dai W; Liang H; Liu JN; Gao J
J Oncol; 2022; 2022():5005747. PubMed ID: 36245978
[TBL] [Abstract][Full Text] [Related]
8. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.
Zhang W; Sun Z; Su L; Wang F; Jiang Y; Yu D; Zhang F; Sun Z; Liang W
Eur J Pharmacol; 2018 Apr; 825():75-84. PubMed ID: 29454608
[TBL] [Abstract][Full Text] [Related]
9. Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2.
Tong SJ; Zhang XY; Guo HF; Yang J; Qi YP; Lu S
Clin Transl Oncol; 2021 Dec; 23(12):2526-2535. PubMed ID: 34086253
[TBL] [Abstract][Full Text] [Related]
10. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity.
Papadas A; Huang Y; Cicala A; Dou Y; Fields M; Gibbons A; Hong D; Lagal DJ; Quintana V; Rizo A; Zomalan B; Asimakopoulos F
Biochem Soc Trans; 2023 Dec; 51(6):2017-2028. PubMed ID: 38031753
[TBL] [Abstract][Full Text] [Related]
12. Current status and prospect of immunotherapy for colorectal cancer.
Yang W; Zheng H; Lv W; Zhu Y
Int J Colorectal Dis; 2023 Nov; 38(1):266. PubMed ID: 37962772
[TBL] [Abstract][Full Text] [Related]
13. Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer.
Chen J; Wu S; Peng Y; Zhao Y; Dong Y; Ran F; Geng H; Zhang K; Li J; Huang S; Wang Z
Front Pharmacol; 2023; 14():1200017. PubMed ID: 37377935
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]